← Back to All Filings

Kenvue Chief Tech Officer Granted 79,407 RSUs

Low SignificanceMarch 4, 2026 at 5:17:31 PM EST

Kenvue Inc.

$KVUE4CIK: 0001944048

Subscribe to track KVUE

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Kenvue Chief Tech Officer Granted 79,407 RSUs

Company: Kenvue Inc. (KVUE) Form: 4 | Filed: 2026-03-04 Significance: Low

Insider: Wondrasch Michael Title: Chief Tech & Data Officer | Relationship: Officer

Transaction: • Type: Grant (Restricted Stock Units) • Shares: 79,407 • Price: $0.00 • Value: $0 (Grant) • Owned After: 79,407

Key Insight: Routine executive compensation grant vesting over three years; not an open market purchase.

Market Context: Transaction represents <0.01% of outstanding shares for this $36.65B market cap company.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Kenvue Inc. (KVUE)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Chief Tech & Data Officer receives standard RSU grant vesting through 2029.
  • Market Impact: Neutral; routine compensation event with negligible dilution.

Company Information

FieldValue
CompanyKenvue Inc.
Ticker SymbolKVUE
CIK0001944048
Market Cap$36.65 Billion

Insider Information

FieldValue
NameWondrasch Michael
CIK0001776065
Title/PositionChief Tech & Data Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-02
Transaction CodeA (Grant)
Security TypeRestricted Stock Units
Shares Involved79,407
Price Per Share$0.00
Total Value$0 (Grant)
Shares Owned After79,407
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Implied Value~$1.52 Million (Est. based on ~$19.13/share)
% of Market Cap~0.004%
Shares Transacted79,407
% of Shares Outstanding~0.004%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a Large Cap company ($36.65B), this grant is immaterial to the broader market structure.
  • Dilution Impact: The issuance of ~79k shares against 1.91 billion outstanding results in virtually zero dilution for existing shareholders.
  • Vesting Schedule: The award vests in three equal installments on March 2 of 2027, 2028, and 2029, incentivizing long-term retention.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a standard compensation grant (Transaction Code 'A') rather than an open market purchase ('P') or sale ('S'). It reflects standard corporate governance rather than insider sentiment regarding stock valuation.

Volume & Sentiment

  • Expected Volume Impact: None.
  • Sentiment Indicator: Neutral. While equity compensation aligns insider interests with shareholders, it does not signal a specific bullish conviction trade.

Additional Context

Transaction Notes

  • Security: Restricted Stock Units (RSUs) convert 1-for-1 to Common Stock upon vesting.
  • Timing: Annual grant cycle timing (March).
  • Conditions: Vesting is subject to continued service through the applicable dates.
Topics:#KVUE#Kenvue#SECFiling#ExecutiveComp#StockGrants#Form4#InsiderActivity#CorporateGovernance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.